Assignment of Assignor's Interest

Recorded: 2017-01-23 Pages: 5

Assignors

MARKOVIC, SVETOMIR N.

Executed: 2013-10-09

NEVALA, WENDY K.

Executed: 2013-10-23

Assignee

200 FIRST STREET, SW, ROCHESTER, MINNESOTA, 55905

Covered Properties (6)

Nanoparticle Complexes of Paclitaxel, Alemtuzumab, and Albumin

Patent: 10,493,150 →

Application: 15/412,610 →

Publication: US 2017/0196832

Nanoparticle Complexes of Paclitaxel, Cetuximab, and Albumin, and Methods of Making the Same

Patent: 10,441,656 →

Application: 15/412,596 →

Publication: US 2017/0128586

Methods for Treating Cancer Using Nanoparticle Complexes of Paclitaxel, Cetuximab, and Albumin

Patent: 10,478,495 →

Application: 15/412,581 →

Publication: US 2017/0128585

Nanoparticle Complexes of Paclitaxel, Cetuximab, and Albumin

Patent: 10,307,482 →

Application: 15/412,564 →

Publication: US 2017/0128584

Methods of Treating Cancer with Antibody-Albumin Nanoparticle Complexes Comprising Albumin, Trastuzumab, and Paclitaxel

Patent: 10,376,580 →

Application: 15/412,554 →

Publication: US 2017/0128583

Nanoparticle Complexes of Paclitaxel, Trastuzumab, and Albumin

Patent: 10,279,035 →

Application: 15/412,536 →

Publication: US 2017/0196831